Skip to main content

. 1955 May;34(5):696–699. doi: 10.1172/JCI103121

THE EFFECTS OF 1-HYDRAZINOPHTHALAZINE UPON CORONARY HEMODYNAMICS AND MYOCARDIAL OXYGEN METABOLISM IN ESSENTIAL HYPERTENSION ^¹

George G Rowe ^1,², John H Huston ^1,³, George M Maxwell ¹, Arvin B Weinstein ¹, Herman Tuchman ¹, Charles W Crumpton ¹, Beryl E Welch ¹, Audrey L Peterson ¹

PMCID: PMC438679 PMID: 14367526

696

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

CROSLEY A. P., Jr, ROWE G. G., CRUMPTON C. W. The hemodynamic and metabolic response of the human hypertensive kidney to a standard dose of 1-hydrazinophthalazine (hydralazine). J Lab Clin Med. 1954 Jul;44(1):104–109. [PubMed] [Google Scholar]
HAFKENSCHIEL J. H., FRIEDLAND C. K. The effects of 1-hydrazinophthalazine on cerebral blood flow, vascular resistance, oxygen uptake and jugular oxygen tension in hypertensive subjects. J Clin Invest. 1953 Jul;32(7):655–660. doi: 10.1172/JCI102778. [DOI] [PMC free article] [PubMed] [Google Scholar]
MOYER J. H., HANDLEY C. A., HUGGINS R. A. Some pharmacodynamic effects of 1-hydrazinophthalazine (C-5968) with particular reference to renal function and cardiovascular response. J Pharmacol Exp Ther. 1951 Dec;103(4):368–376. [PubMed] [Google Scholar]
WILKINSON E. L., BACKMAN H., HECHT H. H. Cardiovascular and renal adjustments to a hypotensive agent (l'hydrazinophthalazine: Ciba BA-5968: apresoline). J Clin Invest. 1952 Oct;31(10):872–879. doi: 10.1172/JCI102674. [DOI] [PMC free article] [PubMed] [Google Scholar]
WILKINS R. W. Combination of drugs in the treatment of essential hypertension. Miss Doct. 1953 Apr;30(11):359–363. [PubMed] [Google Scholar]

ACTIONS

RESOURCES